ArticleMedicine2026
The association of nontraditional lipid parameters with all-cause and cardiovascular mortality: A national cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Nontraditional lipid parameters are increasingly recognized for clinical evaluation, yet their comparative ability to predict mortality risk in the general population remains ambiguous. This study aims to systematically explore the associations between 7 nontraditional lipid parameters and all-cause as well as cardiovascular mortality. This study analyzed data from the National Health and Nutrition Examination Survey database spanning the period from 1999 to 2018, which included 19,710 participants. The participants in this study were classified into 2 distinct categories: survivors (n = 16,364) and non-survivors (n = 3346). The study investigated the relationships between nontraditional lipid parameters and both all-cause and cardiovascular mortality. Cox proportional hazards regression models were utilized to evaluate the associations, supplemented by restricted cubic splines, receiver operating characteristic curves, as well as subgroup, interaction, and sensitivity analyses. Elevated levels of the atherogenic index of plasma and remnant cholesterol were associated with all-cause and cardiovascular mortality in unadjusted analyses, with risk rising progressively as levels increased. These associations were most pronounced in individuals under 65 years but were attenuated after adjustment for potential risk factors. Receiver operating characteristic curve analysis indicated that both parameters exhibited modest predictive capabilities, though their clinical significance requires further investigation. This study suggests that both the atherogenic index of plasma and remnant cholesterol are associated with all-cause and cardiovascular mortality in individuals under 65 years, exhibiting a dose-response relationship. Integrating these readily accessible parameters into age-specific risk stratification may be considered for exploratory purposes, but further validation is required before any clinical application. Future prospective studies are warranted to establish causality and evaluate targeted interventions based on these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.